Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aura Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
AURA
Nasdaq
2836
www.aurabiosciences.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aura Biosciences, Inc.
Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma
- Jun 1st, 2026 6:00 am
Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances
- May 27th, 2026 2:04 pm
Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data
- May 19th, 2026 8:02 pm
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- May 19th, 2026 2:50 pm
Aura Biosciences to Participate in Upcoming Investor Conferences
- May 12th, 2026 2:01 pm
Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights
- May 11th, 2026 2:01 pm
Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- May 5th, 2026 3:15 pm
Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants
- May 4th, 2026 7:03 am
Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- May 4th, 2026 4:03 am
Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion
- May 4th, 2026 4:01 am
Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?
- Apr 22nd, 2026 7:40 am
Does Aura Biosciences (AURA) Have the Potential to Rally 179.84% as Wall Street Analysts Expect?
- Apr 20th, 2026 7:55 am
Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy?
- Apr 10th, 2026 7:55 am
Auranova Announces Closing of Private Placement of Flow-Through Shares
- Apr 7th, 2026 3:15 pm
Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year?
- Apr 6th, 2026 7:40 am
Wall Street Analysts Predict a 201.49% Upside in Aura Biosciences (AURA): Here's What You Should Know
- Apr 2nd, 2026 7:55 am
Auranova Resources and Kenorland Minerals Commence Spring Drill Program at South Uchi Project
- Apr 1st, 2026 5:30 am
Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
- Mar 30th, 2026 5:00 am
Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?
- Mar 20th, 2026 7:40 am
Auranova Resources and Kenorland Minerals Announce Upcoming 2026 Spring Drill Program at The South Uchi Project, Ontario
- Mar 18th, 2026 8:28 am
Scroll